EKEma Kantorová

Ema Kantorová

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ema Kantorová has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Atypical presentation of Charcot-Marie-Tooth disease type 1C with a new mutation: a case report

    by Monika Turčanová Koprušáková, Milan Grofik, Ema Kantorová, Petra Jungová, Ján Chandoga, Martin Kolisek, Peter Valkovič, Matej Škorvánek, Rafal Ploski, Egon Kurča, et al.

    Background: Charcot-Marie-Tooth 1C (CMT1C) is a rare form of dominantly inherited CMT1 neuropathy caused by a mutated gene encoding lipopolysaccharide-induced tumour necrosis alpha factor (LITAF). Case presentation: We report a 56-year-old patient with an atypical clinical phenotype of CMT1C, which started as progressive weakness of a single upper limb resembling acquired inflammatory neuropathy. Nerve conduction studies (NCS) and temporarily limited and partial effects of immunotherapy supported the diagnosis of inflammatory neuropathy. Significant progression of polyneuropathy, despite intensive long-lasting immunotherapy, together with repeatedly negative auxiliary investigations (CSF, MRI and antibodies) and genetic testing results finally led to the diagnosis of CMT1C neuropathy. Conclusions: CMT1C should be added to the list of inherited neuropathies that need to be considered in suspected cases of inflammatory demyelinating neuropathy.


  • Open Access

    Significance of multiple sclerosis early treatment

    by Ema Kantorová

    Sclerosis multiplex je chronické ochorenie postihujúce najmä mladých dospelých ľudí. Správne načasovanie liečby určuje ďalší priebeh ochorenia a pozitívne ovplyvňuje kvalitu života. Práca prináša nové pohľady na diagnostiku

  • Open Access

    Epileptic seizures in patients with multiple sclerosis

    by Ema Kantorová, Babeta Hofericová, Egon Kurča

    Epileptické záchvaty sú definované ako tranzientné prejavy dezinhibovanej, extrémne synchronizovanej kortikálnej aktivity

  • Open Access

    The role of vaspin as a predictor of coronary angiography result in SCAD (stable coronary artery disease) patients

    by Matej Stančík, Ivana Ságová, Ema Kantorová, Marián Mokáň

    The role of vaspin in the pathogenesis of stable coronary artery disease (SCAD) have been repeatedly addressed in clinical studies. However, from the point of view of clinical practice, the results of earlier studies are still inconclusive. The data of 106 SCAD patients who received coronary angiography and 85 coronary artery disease-free controls were collected and analysed. The patients were divided into subgroups according to their pre-test probability (PTP) and according to the result of coronary angiography. Fasting vaspin concentrations were compared between subgroups of SCAD patients and between target group and controls. The effect of age and smoking on the result of coronary angiography was compared to the effect of vaspin using the binomial regression. We did not find significant difference in vaspin level between target group and controls. Unless the pre-test probability was taken into account, we did not find vaspin difference in the target group, when dividing patients on the basis of presence/absence of significant coronary stenosis. In the subgroup of SCAD patients with PTP between 15% – 65%, those with significant coronary stenoses had higher mean vaspin concentration (0,579 ± 0,898 ng/ml) than patients without significant stenoses. (0,379 ± 0,732 ng/ml) (t = −2595; p = 0,012; d = 0,658; 1-β = 0,850). Age, smoking status and vaspin significantly contributed to the HSCS prediction in binomial regression model in patients with low PTP (OR: 1.1, 4.9, 8.7, respectively). According to our results, vaspin cannot be used as an independent marker for the presence of CAD in general population. However, our results indicate that measuring vaspin in SCAD patients might be clinically useful in patients with PTP below 66%.


  • Open Access

    Tumefactive demyelination of the spinal cord: a case report

    by E Kantorová, J Marcinek, K Zeleňák, K Kantor, J Michalik, Š Sivák, E Kurča, L Plank

    Study design: Case report. Objectives: We report on a 52-year-old male patient with tumefactive demyelination of the spinal cord. Setting: University Hospital and Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. Background: In contrast to relatively frequent tumefactive fulminant lesions in the brain, cases affecting the spinal cord in isolation have been reported less frequently. Methods: Description of the case report. Results: Clinical, neuroradiological and necropsy findings are described in a 52-year-old man with tumefactive fulminant demyelination of the spinal cord. Progression of the demyelination process produced paraplegia, mild paresis of the right upper limb, neurogenic bladder and sensitive loss over 2 weeks. MRI scans revealed several ovoid lesions in cervical segments and tumefactive T2-hyperintense signals with oedema and post-contrast enhancement located in thoracic segments Th3 to Th6. Cerebrospinal fluid (CSF) examination displayed lymphomonocytic pleocytosis with normal proteinorhachia, positive CSF oligoclonal IgG bands (OCB) and elevated IgG index (1.55). Serum anti-AQP4-Ab was not tested. Stored frozen CSF samples were later repeatedly examined with negative findings of anti-AQP4-Ab. Treatment with high-dose methylprednisolon and plasma exchange had limited effect. Immunosuppressive medication was interrupted because of an acute urinary infection. The patient died suddenly because of pulmonary embolism as a secondary complication. Histopathology of the spinal cord confirmed active demyelination. We considered that tumefactive demyelination could be a variant of neuromyelitis optica. Conclusion: Our case could be anti-AQP4-Ab-negative longitudinally extensive transverse myelitis, a variant of neuromyelitis optica.


  • Open Access

    Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation

    by Ema Kantorová, Peter Žiak, Egon Kurča, Mária Koyšová, Mária Hladká, Kamil Zeleňák, Jozef Michalik

    Backround: The aim of our study was to assess the role of laser polarimetry and visual evoked potentials as potential biomarkers of disease progression in multiple sclerosis (MS). Participants: A total of 41 patients with MS (82 eyes) and 22 age-related healthy volunteers (44 eyes) completed the study. MS patients were divided into two groups, one (ON) with a history of optic neuritis (17 patients, 34 eyes) and another group (NON) without it (24 patients, 48 eyes). The MS patients and controls underwent laser polarimetry (GDx) examination of the retinal nerve fibre layer (RNFL). In the MS group we also examined: Kurtzke "Expanded disability status scale" (EDSS), the duration of the disorder, visual evoked potentials (VEP) – latency and amplitude – and conventional brain MRI. Results: In the MS group, brain atrophy and new T2 brain lesions in MRI correlated with both VEP latencies and amplitudes. Separate comparisons revealed VEP latency testing to be less sensitive in ON than in NON patients. In ON patients, VEP amplitudes correlated mildly with brain atrophy (r =-0.15) and strongly with brain new MRI lesions (r = -0.8). In NON patients, highly significant correlation of new MRI brain lesions with VEP latencies (r = 0.63, r = 0.6), and amplitudes ( r = -0.3, r = -4.2) was found. EDSS also correlated with brain atrophy in this group (r = 0.5). Our study did not find a correlation of GDx measures with MRI tests. The GDx method was not able to detect whole brain demyelinisation and the degeneration process, but was only able to reveal the involvement of optic nerves in ON and NON patients.Conclusions: In our study, we found that both methods (VEP and GDx) can be used for detection of optic nerve damage, but VEP was found to be superior in evaluating whole brain demyelinisation and axonal degeneration. Both VEP and MRI, but not GDx, have an important role in monitoring disease progression in MS patients, independent of the ON history.


    • 1 January 2011
      • Vol. 32  (5) , 716-21

    Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke.

    by Ema Kantorova, Maria Chomova, Egon Kurca, Štefan Sivák, Kamil Zelenak, Pavol Kučera, Peter Galajda

    Fat tissue is an important endocrine organ that produces a number of hormones and cytokines (leptin, adiponectin, resistin, plasminogen activator inhibitor-1, Tumour necrosis factor TNF α) with essential roles in regulation of many physiological functions. We targeted implications of adipokines in ischemic stroke patients. Patients with acute stroke were examined (n=145) and the results were compared with the control group (n=68). We have examined potential associations between leptin, adiponectin and ghrelin, and different types of stroke and traditional risk factors. Significantly higher levels of leptin and lower levels of adiponectin and ghrelin were confirmed in the stroke group. The level of leptin in women with stroke was three-times higher than in men, and the leptin levels positively correlated with obesity in both sexes. Ghrelin levels correlated mildly with triglyceride levels, and were dominant in men with cardioembolic stroke. Adiponectin levels were not different between men and women with acute stroke, and correlated with atherothrombotic and lacunar stroke types in men. Adipokines and ghrelin play an important role in ischemic stroke, but their function in stroke subtypes seems to be different and sex influenced. More research is required to confirm our results.